삼성서울병원

Ko En

Breast Surgery Nam, Seok Jin M.D

Expertise
Treament Schedule 01 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM
Treament Schedule 02 月
DATE
SAT
01
SUN
02
MON
03
TUE
04
WEB
05
THU
06
FRI
07
SAT
08
SUN
09
MON
10
TUE
11
WEB
12
THU
13
FRI
14
SAT
15
SUN
16
MON
17
TUE
18
WEB
19
THU
20
FRI
21
SAT
22
SUN
23
MON
24
TUE
25
WEB
26
THU
27
FRI
28
AM
PM

Medical Education

Seoul National University College of Medicine

Post-Graduate Training

Fellowship   Samsung Medical Center
Residency   Seoul National University Hospital
Internship   Seoul National University Hospital

Professional Appointments

University of Virginia Health System, VA, USA

Professional Memberships

Korean Medical Association
Korean Surgical Society
Korean Association of Endocrine Surgeons
Korean Breast Cancer Society
Korean Cancer Association

Selected Publications

  • INT J CLIN PRACT 2024 10.1155/2024/1805803 Outcomes of Tamoxifen Treatment Alone in Patients With Ductal Carcinoma In Situ or Atypical Ductal Hyperplasia Who Refused Surgery Kwak, Y; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • CANCER-AM CANCER SOC 2024 10.1002/cncr.35567 Nonsentinel lymph node metastases in cases of micrometastasis detected by sentinel lymph node biopsy after neoadjuvant chemotherapy Shin, DS; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • EJSO-EUR J SURG ONC 2024 10.1016/j.ejso.2024.108644 Evaluating the feasibility of repeat sentinel lymph node biopsy in ipsilateral breast tumor recurrence: Technical considerations and oncologic outcomes Park, WK; Kim, HJ; Ryu, JM; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • INT J BIOL SCI 2024 10.7150/ijbs.96487 METTL18 functions as a Phenotypic Regulator in Src-Dependent Oncogenic Responses of HER2-Negative Breast Cancer Kim, HG; Kim, JH; Kim, KH; Yoo, BC; Kang, SU; Kim, YB; Kim, S; Paik, HJ; Lee, JE; Nam, SJ; Parameswaran, N; Han, JW; Manavalan, B; Cho, JY
    View PubMed
  • CANCERS 2024 10.3390/cancers16142566 The Prognostic Impact of HER2-Low and Menopausal Status in Triple-Negative Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Ryu, JM; Chae, B
    View PubMed
  • NPJ BREAST CANCER 2024 10.1038/s41523-024-00669-9 Prognostic value of structural variants in early breast cancer patients Kim, JY; Park, K; Park, WY; Ahn, JS; Im, YH; Lee, JE; Kim, SW; Nam, SJ; Yu, J; Park, YH
    View PubMed
  • CANCERS 2024 10.3390/cancers16101865 The Effects of National Insurance Coverage Expansion and Genetic Counseling's Role on BRCA1/2 Mutation Tests in Breast Cancer Patients Jang, SY; Kwak, Y; Choi, JY; Shin, DS; Lee, H; Kim, M; Jung, BY; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • BREAST CANCER RES 2024 10.1186/s13058-024-01807-8 Outcomes of sentinel node biopsy according to MRI response in an association with the subtypes in cN1-3 breast cancer after neoadjuvant systemic therapy, multicenter cohort study Bae, SJ; Chun, JW; Lee, SB; Ryu, JM; Nam, SJ; Jeong, J; Park, HS; Ahn, SG
    View PubMed
  • NPJ PRECIS ONCOL 2024 10.1038/s41698-024-00559-0 Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations Park, WK; Chung, SY; Jung, YJ; Ha, C; Kim, JW; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, JE; Kim, SW; Ryu, JM
    View PubMed
  • BMC WOMENS HEALTH 2024 10.1186/s12905-024-02973-9 Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients Kim, EY; Lee, KH; Yun, JS; Park, YL; Park, CH; Jang, SY; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01559-5 Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile Kang, DB; Park, S; Kim, HJ; Lee, JS; Han, JY; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Cho, JH; Park, YH
    View PubMed
  • J BREAST CANCER 2024 10.4048/jbc.2023.0196 Oncologic Outcomes of Immediate Breast Reconstruction in the Setting of Neoadjuvant Chemotherapy: A Long-term Follow-up Study of a Matched Cohort Shin, DS; Bang, YJ; Choi, JY; Jang, SY; Lee, H; Kwak, Y; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Jeon, BJ; Pyon, JK; Mun, GH; Lee, KT; Ryu, JM
    View PubMed
  • BREAST CANCER-TOKYO 2024 10.1007/s12282-024-01547-9 Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H
    View PubMed
  • QUAL LIFE RES 2024 10.1007/s11136-024-03599-y Social support during re-entry period and long-term quality of life in breast cancer survivors: a 10-year longitudinal cohort study Cho, H; Kang, DB; Shin, DW; Kim, N; Lee, SK; Lee, JE; Nam, SJ; Cho, J
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.673 Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study Kang, D; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Kim, JY; Nam, SJ; Cho, J; Park, YH
    View PubMed
  • BREAST 2023 10.1016/j.breast.2023.103594 Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H
    View PubMed
  • INT J MOL SCI 2023 10.3390/ijms242115576 A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • CANCERS 2023 10.3390/cancers15225361 The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ
    View PubMed
  • CANCERS 2023 10.3390/cancers15225473 The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1230310 Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15194720 Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer Shin, J; Kim, JY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, W; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • WORLD J CLIN CASES 2023 10.12998/wjcc.v11.i27.6398 Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY
    View PubMed
  • THER ADV MED ONCOL 2023 10.1177/17588359231189421 Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study Kang, DB; Cho, JH; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Park, YH
    View PubMed
  • JMIR PUBLIC HLTH SUR 2023 10.2196/45212 Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK
    View PubMed
  • CANCERS 2023 10.3390/cancers15133435 Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • EXP MOL MED 2023 10.1038/s12276-023-01030-z Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.105.1.10 Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • CANCERS 2023 10.3390/cancers15092646 Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer Lee, H; Choi, JY; Park, YH; Lee, JE; Kim, SW; Nam, SJ; Cho, YS
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e17 Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.939 Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients? Returning to Work (START): A Multi-center, Randomized Controlled Trial Kang, DB; Bae, KR; Ahn, Y; Kim, N; Nam, SJ; Lee, JE; Lee, SK; Shim, YM; Sinn, DH; Oh, SY; Chun, M; Heo, J; Cho, JH
    View PubMed
  • CANCERS 2023 10.3390/cancers15051556 Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J
    View PubMed
  • BIOMEDICINES 2023 10.3390/biomedicines11030675 Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells Kim, S; Kim, H; Jeong, Y; You, D; Yoon, SY; Lo, EJ; Nam, SJ; Lee, JE; Kim, SW
    View PubMed
  • ANN SURG TREAT RES 2023 10.4174/astr.2023.104.3.137 The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1039670 The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e49 Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW
    View PubMed
  • ANN SURG TREAT RES 2022 10.4174/astr.2022.103.6.313 Omission of chemotherapy for hormone receptor-positive and human epidermal growth factor receptor 2-negative breast cancer: patterns of treatment and outcomes from the Korean Breast Cancer Society Registry Kangleon-Tan, HL; Sim, J; Yoo, JY; Lee, ES; Lee, H; Yang, SM; Seong, MK; Park, EH; Nam, SJ; Park, MH; Lee, S; Park, WC; Kangleon, RG; Dy, CB; Bae, SY; Jung, SP
    View PubMed
  • EJSO-EUR J SURG ONC 2022 10.1016/j.ejso.2022.07.005 Survival benefit from axillary surgery in patients aged 70 years or older with clinically node-negative breast cancer: A population-based propensity-score matched analysis Cha, C; Jeong, J; Kim, HK; Nam, SJ; Seong, MK; Woo, J; Park, WC; Ryu, S; Chung, MS; Korean Breast Canc Soc
    View PubMed
  • BREAST 2022 10.1016/j.breast.2022.09.004 Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ
    View PubMed
  • J CLIN MED 2022 10.3390/jcm11216564 Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy? Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.901 Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH
    View PubMed
  • CANCERS 2022 10.3390/cancers14194839 Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e36 Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.791 Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.784 Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.903372 Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy Kim, JY; Oh, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kim, K; Im, YH
    View PubMed
  • CURR ONCOL 2022 10.3390/curroncol29050267 Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE
    View PubMed
  • J BREAST CANCER 2022 10.4048/jbc.2022.25.e17 Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE
    View PubMed
  • VIRCHOWS ARCH 2022 10.1007/s00428-022-03280-0 Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • BREAST CANCER RES TR 2022 10.1007/s10549-021-06483-2 Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG
    View PubMed
  • CANCERS 2021 10.3390/cancers13215260 Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • J CLIN MED 2021 10.3390/jcm10204754 Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • BREAST CANCER RES TR 2021 10.1007/s10549-021-06309-1 Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea Park, YH; Karantza, V; Calhoun, SR; Park, S; Lee, S; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Nam, SJ; Aktan, G; Marsico, M
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.741120 Axillary Lymph Node Dissection Rates and Prognosis From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer Gwark, S; Noh, WC; Ahn, SH; Lee, ES; Jung, Y; Kim, LS; Han, W; Nam, SJ; Gong, G; Kim, SO; Kim, HJ
    View PubMed
  • J BREAST CANCER 2021 10.4048/jbc.2021.24.e30 Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • SUPPORT CARE CANCER 2021 10.1007/s00520-021-06459-4 Effect of mind and body education on quality of life among young breast cancer patients: a randomized controlled trial Kang, D; Lee, JK; Kim, N; Kim, S; Lee, SK; Lee, JE; Nam, SJ; Cho, J
    View PubMed
  • PSYCHO-ONCOLOGY 2021 10.1002/pon.5690 Association between cancer stigma and job loss among cancer survivors Shim, S; Kang, D; Bae, KR; Lee, WY; Nam, SJ; Sohn, TS; Jeong, BC; Sinn, DH; Kweon, SS; Shim, YM; Cho, J
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-94195-4 Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e194 Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.608207 Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer Gwark, S; Ahn, SH; Noh, WC; Lee, ES; Jung, Y; Kim, LS; Han, W; Nam, SJ; Gong, G; Kim, SO; Kim, HJ
    View PubMed
  • BREAST CANCER RES TR 2021 10.1007/s10549-021-06310-8 Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer Kim, JY; Jeon, E; Kwon, S; Jung, H; Joo, S; Park, Y; Lee, SK; Lee, JE; Nam, SJ; Cho, EY; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.691277 Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea Lee1, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM
    View PubMed
  • MOLECULES 2021 10.3390/molecules26123644 Entelon(R) (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells You1, D; Jeong, Y; Yoon, SY; Kim, SA; Lo, E; Kim, SW; Lee, JE; Nam, SJ; Kim, S
    View PubMed
  • ONCOL REP 2021 10.3892/or.2021.8040 Celastrol attenuates the inflammatory response by inhibiting IL-1 beta expression in triple-negative breast cancer cells You1, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE; Kim, S
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.596364 Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry Kim1, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e17 Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006) Ahn1, SG; Nam, SJ; Ahn, SH; Jung, YS; Park, HK; Lee, SJ; Kang, SS; Han, WS; Park, KH; Park, YL; Lee, J; Youn, HJ; Kim, JH; Yoo, Y; Song, JY; Ko, BK; Gwak, G; Chung, MS; Kim, SY; Cho, SH; Kim, D; Chang, MC; Moon, BI; Kim, LS; Kim, SJ; Park, MH; Kim, TH; Cho, J; Lim, CW; Bae, YT; Gong, G; Bae, YK; Lee, A; Jeong, J
    View PubMed
  • BMC SURG 2021 10.1186/s12893-021-01129-y The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW
    View PubMed
  • J BREAST CANC 2021 10.4048/jbc.2021.24.e4 Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer Min1, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.588728 Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer Kwon1, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE
    View PubMed
  • EJSO-EUR J SURG ONC 2021 10.1016/j.ejso.2020.08.023 Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer Woo1, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ
    View PubMed
  • BMC CANCER 2021 10.1186/s12885-020-07729-w Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander? Jung1, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE
    View PubMed
  • ANN SURG ONCOL 2021 10.1245/s10434-021-09591-x Survival of Breast-Conserving Surgery Plus Radiotherapy versus Total Mastectomy in Early Breast Cancer Kim1, H; Lee, SB; Nam, SJ; Lee, ES; Park, BW; Park, HY; Lee, HJ; Kim, J; Chung, Y; Kim, HJ; Ko, BS; Lee, JW; Son, BH; Ahn, SH
    View PubMed
  • NAT COMMUN 2020 10.1038/s41467-020-19933-0 Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome Park1, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z
    View PubMed
  • JAMA SURG 2020 10.1001/jamasurg.2020.4124 Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence Lee1, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI
    View PubMed
  • IN VIVO 2020 10.21873/invivo.12151 Response of Triple-negative Breast Cancer Liver Metastasis to Oral Recombinant Methioninase in a Patient-derived Orthotopic Xenograft (PDOX) Model Lim1, HI; Yamamoto, J; Han, QH; Sun, YU; Nishino, H; Tashiro, Y; Sugisawa, N; Tan, YY; Choi, HJ; Nam, SJ; Bouvet, M; Hoffman, RM
    View PubMed
  • CYTOKINE 2020 10.1016/j.cyto.2020.155213 WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells Kim1, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.99.5.251 Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer? Jung1, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE
    View PubMed
  • ASIA-PAC J CLIN ONCO 2020 10.1111/ajco.13444 Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer Kim1, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9092846 Impact of Serum Lipid on Breast Cancer Recurrence Jung1, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK
    View PubMed
  • SCI REP-UK 2020 10.1038/s41598-020-72033-3 Dynamic and subtype-specific interactions between tumour burden and prognosis in breast cancer Lee1, SB; Kim, HK; Choi, Y; Ju, YW; Lee, HB; Han, W; Noh, DY; Son, BH; Ahn, SH; Kim, KS; Nam, SJ; Kim, EK; Park, HY; Park, WC; Lee, JW; Moon, HG
    View PubMed
  • IN VIVO 2020 10.21873/invivo.12039 Oral Methioninase Inhibits Recurrence in a PDOX Mouse Model of Aggressive Triple-negative Breast Cancer Lim1, HI; Hamada, K; Yamamoto, J; Han, QH; Tan, YY; Choi, HJ; Nam, SJ; Bouvet, M; Hoffman, RM
    View PubMed
  • MOL CANCER RES 2020 10.1158/1541-7786.MCR-19-1108 Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer Park1, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH
    View PubMed
  • BREAST CANCER RES TR 2020 10.1007/s10549-020-05874-1 Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer Kim1, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • BRIT J SURG 2020 10.1002/bjs.11572 Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence Lee1, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ
    View PubMed
  • BREAST CANCER RES 2020 10.1186/s13058-020-01288-5 Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer Kim1, HJ; Noh, WC; Lee, ES; Jung, YS; Kim, LS; Han, W; Nam, SJ; Gong, GY; Kim, HJ; Ahn, SH
    View PubMed
  • ANN SURG TREAT RES 2020 10.4174/astr.2020.98.5.215 Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study Kim1, J; Cho, J; Lee, SK; Choi, EK; Kim, IR; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • ANTICANCER RES 2020 10.21873/anticanres.14218 A Single Low Dose of Eribulin Regressed a Highly Aggressive Triple-negative Breast Cancer in a Patient-derived Orthotopic Xenograft Model Lim1, HI; Yamamoto, J; Inubushi, S; Nishino, H; Tashiro, Y; Sugisawa, N; Han, QH; Sun, Y; Choi, HJ; Nam, SJ; Kim, MB; Lee, JS; Hozumi, C; Bouvet, M; Singh, SR; Hoffman, RM
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041192 Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence Ryu1, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK
    View PubMed
  • BRIT J SURG 2020 10.1002/bjs.11572 Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence Lee1, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ
    View PubMed
  • PSYCHO-ONCOL 2020 10.1002/pon.5394 Efficacy of health coaching and a web-based program on physical activity, weight, and distress management among cancer survivors: A multi-centered randomised controlled trial Yun1, YH; Lim, CI; Lee, ES; Kim, YT; Shin, KH; Kim, YW; Park, KJ; Jeong, SY; Ryu, KW; Han, W; Jung, KH; Park, SC; Kim, MS; Kim, S; Shim, YM; Oh, JH; Lee, JM; Ryoo, SB; Woo, J; Noh, DY; Park, JW; Moon, BI; Kim, HJ; Nam, SJ; Lee, DH; Zo, JI; Park, SM; Kang, E; Rhee, Y; Jung, JY; Sim, JA; Lee, J; Shin, A
    View PubMed
  • JPN J CLIN ONCOL 2020 10.1093/jjco/hyz147 Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors Ryu1, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J
    View PubMed
  • J CLIN ONCOL 2020 10.1200/JCO.19.00126 Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial Kim1, HA; Lee, JW; Nam, SJ; Park, BW; Im, SA; Lee, ES; Jung, YS; Yoon, JH; Kang, SS; Lee, SJ; Park, KH; Jeong, J; Cho, SH; Kim, SY; Kim, LS; Moon, BI; Lee, MH; Kim, TH; Park, C; Jung, SH; Gwak, G; Kim, J; Kang, SH; Jin, YW; Kim, HJ; Han, SH; Han, W; Hur, MH; Noh, WC
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e48 Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm Alsharif1, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05372-z Survival benefit of postoperative radiotherapy for ductal carcinoma in situ after breast-conserving surgery: a Korean population-based cohort study Kim1, BH; Ko, BK; Bae, JW; Nam, S; Park, MH; Jeong, J; Lee, HJ; Chang, JH; Kim, S; Hwang, KT
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05214-y Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-019-05157-4 Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort Jung1, J; Han, W; Lee, ES; Jung, SY; Han, JH; Noh, DY; Kim, Y; Choi, HJ; Lee, JE; Nam, SJ; Lee, JW; Kim, HJ; Um, E; Kim, JH; Park, S; Cho, YU
    View PubMed
  • ANN SURG TREAT RES 2019 10.4174/astr.2019.96.4.169 Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer Choi1, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK
    View PubMed
  • ONCOLOGIST 2019 10.1634/theoncologist.2018-0184 Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study Kang1, D; Kim, IR; Choi, EK; Im, YH; Park, YH; Ahn, JS; Lee, JE; Nam, SJ; Lee, HK; Park, JH; Lee, DY; Lacouture, ME; Guallar, E; Cho, J
    View PubMed
  • ONCOL REP 2019 10.3892/or.2018.6910 TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • EJSO-EUR J SURG ONC 2019 10.1016/j.ejso.2018.09.011 A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • PLoS One 2019 10.1371/journal.pone.0212309 Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment Kwon1, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4981-x A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients Hwang1, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY
    View PubMed
  • NUTRIENTS 2019 10.3390/nu11010037 Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients Choi1, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-4947-z Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? Lee1, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ
    View PubMed
  • HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3 The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e50 Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study Choi1, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4948-y Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer Ryu1, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e48 PIK3CA Mutations and Neoadjuvant Therapy Outcome in Patients with Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Sequential Analysis Seo1, Y; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Cho, SY; Cho, EY
    View PubMed
  • KAOHSIUNG J MED SCI 2018 10.1016/j.kjms.2018.07.003 Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer Bae1, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e54 Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis Choi1, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4892-x Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study Lee1, SB; Ko, SS; Park, CH; Nam, SJ; Choi, JE; Jung, YS; Park, WC; Son, BH
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4928-2 Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer Bae1, SY; Nam, SJ; Jung, Y; Lee, SB; Park, BW; Lim, W; Jung, SH; Yang, HW; Jung, SP
    View PubMed
  • PHYTOMEDICINE 2018 10.1016/j.phymed.2018.08.004 Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells Kim1, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0207155 BCT score predicts chemotherapy benefit in Asian patients with hormone receptor- positive, HER2-negative, lymph node-negative breast cancer Kwon1, MJ; Lee, SB; Han, J; Lee, JE; Lee, JW; Gong, G; Beitsch, PD; Nem, SJ; Ahn, SH; Nam, BH; Shin, YK
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010 Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.008 Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy Kim1, HJ; Lee, MH; Lee, JE; Park, S; Lee, ES; Kang, YJ; Shin, HN; Kim, SI; Lee, JH; Im, SA; Ahn, SH; Lee, KS; Sohn, J; Kim, S; Nam, SJ; Han, W
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4858-z Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort Kim1, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH
    View PubMed
  • ONCOLOGY-BASEL 2018 10.1159/000488944 Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype Bae1, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • RADIOLOGY 2018 10.1148/radiol.2018171987 Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection Kim1, GR; Choi, JS; Han, BK; Lee, JE; Nam, SJ; Ko, EY; Ko, ES; Lee, SK
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.222 Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer Kim1, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.206 Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.173 Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer Kim1, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.182 Assessment of Quality of Life and Safety in Postmenopausal Breast Cancer Patients Receiving Letrozole as an Early Adjuvant Treatment Jung1, Y; Lee, SJ; Lee, J; Noh, WC; Nam, SJ; Park, BW; Bae, YT; Kang, SS; Parks, HK; Yoon, JH; Kim, JR; Cho, SH; Kim, LS; Moon, BI; Jung, SH; Lim, CW; Kim, SY; Park, HY; Song, J; Lee, KM; Park, SH; Jeong, J; Park, HL; Kim, SW; Kwak, BS; Kang, SH; Cho, YU; Gwak, GH; Park, YL; Kim, SW; Han, S
    View PubMed
  • WORLD J SURG 2018 10.1007/s00268-017-4342-7 Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer Park1, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0197523 The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer Lim1, ST; Park, CH; Kim, SY; Nam, SJ; Kang, EY; Moon, BI; Lee, HJ; Jeon, YW; Gwak, H; Suh, YJ
    View PubMed
  • EUR J CANCER PREV 2018 10.1097/CEJ.0000000000000353 Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study Shin1, J; Lee, JE; Ko, HY; Nguyen, TL; Nam, SJ; Hopper, JL; Song, YM
    View PubMed
  • NAT COMMUN 2018 10.1038/s41467-018-04129-4 Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures Kan1, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.91 Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy Park1, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.1.21 Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells Jeong1, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S
    View PubMed
  • CELL PHYSIOL BIOCHEM 2018 10.1159/000487171 Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells Kim1, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • QUAL LIFE RES 2018 10.1007/s11136-017-1723-1 Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors Yun1, YH; Jung, JY; Sim, JA; Lee, J; Noh, DY; Han, W; Park, KJ; Jeong, SY; Park, JW; Wu, HG; Chie, EK; Kim, HJ; Jung, KH; Zo, JI; Kim, S; Lee, JE; Nam, SJ; Lee, ES; Oh, JH; Kim, YW; Kim, YT; Shim, YM
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2017.06.003 Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane Park1, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.002 Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast Kim1, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE
    View PubMed
  • BMC CANCER 2018 10.1186/s12885-017-3965-2 A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors Park1, E; Yoon, J; Choi, EK; Kim, IR; Kang, D; Lee, SK; Lee, JE; Nam, SJ; Ahn, JS; Visser, A; Cho, J
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4472-5 Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society Ryu1, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW
    View PubMed
  • PSYCHO-ONCOL 2017 10.1002/pon.4408 Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor Kang1, D; Kim, IR; Choi, EK; Yoon, JH; Lee, SK; Lee, JE; Nam, SJ; Han, W; Noh, DY; Cho, J
    View PubMed
  • JAMA Oncol 2017 10.1001/jamaoncol.2017.1256 Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy Cho1, N; Han, W; Han, BK; Bae, MS; Ko, ES; Nam, SJ; Chae, EY; Lee, J; Kim, SH; Kang, BJ; Song, BJ; Kim, EK; Moon, HJ; Il Kim, S; Kim, SM; Kang, E; Choi, Y; Kim, HH; Moon, WK
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22220 Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer Woo1, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY
    View PubMed
  • CLIN BREAST CANCER 2017 10.1016/j.clbc.2017.03.014 Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis Ryu1, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.21198 Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy Kim1, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.18618 Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients Jeong1, HM; Kim, RN; Kwon, MJ; Oh, E; Han, J; Lee, SK; Choi, JS; Park, S; Nam, SJ; Gong, GY; Nam, JW; Choi, DH; Lee, H; Nam, BH; Choi, YL; Shin, YK
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.203.270 Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy Kim1, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.3.297 Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry You1, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE
    View PubMed
  • ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652 Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.10843 Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction Jeon1, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE
    View PubMed
  • BREAST CANCER RES TR 2017 10.1007/s10549-017-4234-4 MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer Han1, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):91-97. doi: 10.4048/jbc.2017.20.1.91. Epub 2017 Mar 24. Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy Kim I11, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):1-11. doi: 10.4048/jbc.2017.20.1.1. Epub 2017 Mar 24. Basic Facts of Breast Cancer in Korea in 2014:The 10-Year Overall Survival Progress Park EH11, Min SY2, Kim Z3, Yoon CS4, Jung KW5, Nam SJ6, Oh SJ7, Lee S8, Park BW9, Lim W10, Hur MH11; Korean Breast Cancer Society.
    View PubMed
  • J Breast Cancer. 2017 Mar;20(1):74-81. doi: 10.4048/jbc.2017.20.1.74. Epub 2017 Mar 24. Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study Ryu JM11, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.
    View PubMed
  • Breast Cancer Res Treat. 2017 Feb;161(3):443-452. doi: 10.1007/s10549-016-4065-8. Epub 2016 Dec 8. Effects of exercise intervention in breast cancer patients: is mobile health (mHealth) with pedometer more effective than conventional program using brochure? Uhm KE11,2, Yoo JS3, Chung SH3, Lee JD4, Lee I4,5, Kim JI4, Lee SK6, Nam SJ6, Park YH7, Lee JY8, Hwang JH9.
    View PubMed
  • Clin Breast Cancer. 2017 Feb;17(1):e19-e29. doi: 10.1016/j.clbc.2016.06.020. Epub 2016 Jul 9. Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer Park S11, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.
    View PubMed
  • INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10(2):1738-1746 Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy Yoon N1, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY
    View PubMed
  • Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
    View PubMed
  • Medicine (Baltimore). 2017 Jan;96(1):e5746. doi: 10.1097/MD.0000000000005746. Conditional disease-free survival among patients with breast cancer Paik HJ11, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.
    View PubMed
  • Breast. 2016 Dec;30:111-117. doi: 10.1016/j.breast.2016.08.011. Epub 2016 Sep 30. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype Alramadhan M11, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.
    View PubMed
  • Genet Med. 2016 Dec;18(12):1250-1257. doi: 10.1038/gim.2016.39. Epub 2016 Apr 28. Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants Park KS11, Cho EY2, Nam SJ3, Ki CS4, Kim JW4.
    View PubMed
  • Breast Cancer Res Treat. 2016 Dec;160(3):475-489. doi: 10.1007/s10549-016-4008-4. Epub 2016 Oct 11. Assessment of pathologic response and long-term outcome in locally advanced breast cancers after neoadjuvant chemotherapy: comparison of pathologic classification systems Choi M11, Park YH2, Ahn JS2, Im YH2, Nam SJ3, Cho SY4, Cho EY5.
    View PubMed
  • Breast Cancer Res Treat. 2016 Oct;159(3):489-98. doi: 10.1007/s10549-016-3943-4. Epub 2016 Sep 2. Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society Ryu JM11, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.
    View PubMed
  • Chem Biol Interact. 2016 Oct 25;258:126-33. doi: 10.1016/j.cbi.2016.08.021. Epub 2016 Aug 25. Elevated IL-1 beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone Jeon M11, Han J2, Nam SJ2, Lee JE3, Kim S4.
    View PubMed
  • PLoS One. 2016 Oct 31;11(10):e0165814. doi: 10.1371/journal.pone.0165814. eCollection 2016. Body Mass Index with Tumor F-18-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer Hyun SH11, Ahn HK2, Lee JH1, Choi JY1, Kim BT1, Park YH3, Im YH3, Lee JE4, Nam SJ4, Lee KH1.
    View PubMed
  • Cancer Res Treat. 2016 Oct;48(4):1382-1388. Epub 2016 Mar 11. Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea Kim HK11, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.
    View PubMed
  • Oncol Rep. 2016 Sep;36(3):1717-22. doi: 10.3892/or.2016.4972. Epub 2016 Jul 25. STC-1 expression is upregulated through an Akt/NF-B-dependent pathway in triple-negative breast cancer cells Jeon M11, Han J1, Nam SJ1, Lee JE1, Kim S1.
    View PubMed
  • PLoS One. 2016 Sep 20;11(9):e0163254. doi: 10.1371/journal.pone.0163254. eCollection 2016. Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series Lee MY11, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.
    View PubMed
  • SCIENTIFIC REPORTS, AUG 22 2016, 6, DOI: 10.1038/srep31804 The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment Kim JY1, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH
    View PubMed
  • Tumour Biol. 2016 Aug;37(8):11397-407. doi: 10.1007/s13277-016-5000-7. Epub 2016 Mar 16. Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-beta 2 expression Kim S11, Han J2, Jeon M2,3, You D2,3, Lee J2, Kim HJ2, Bae S2, Nam SJ2, Lee JE4,5.
    View PubMed
  • World J Surg. 2016 Aug;40(8):2028-35. doi: 10.1007/s00268-016-3487-0. Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm Ryu JM11, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19. Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer Kim H11, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.
    View PubMed
  • J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24. Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes Kim SW11, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Genes Chromosomes Cancer. 2016 Jun;55(6):495-504. doi: 10.1002/gcc.22351. Epub 2016 Mar 3. Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade Yoon N11, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.
    View PubMed
  • BMC Cancer. 2016 May 19;16:319. doi: 10.1186/s12885-016-2354-6. The role of the addition of ovarian suppression to tamoxifen in young women with hormone-sensitive breast cancer who remain premenopausal or regain menstruation after chemotherapy (ASTRRA): study protocol for a randomized controlled trial and progress Kim HA11, Ahn SH2, Nam SJ3, Park S4, Ro J5, Im SA6, Jung YS7, Yoon JH8, Hur MH9, Choi YJ10, Lee SJ11, Jeong J12, Cho SH13, Kim SY14, Lee MH15, Kim LS16, Moon BI17, Kim TH18, Park C19, Kim SJ20, Jung SH21, Park H22, Gwak GH23, Kang SH24, Kim JG25, Kim J26, Choi SY27, Lim CW28, Kim D29, Yoo Y30, Song YJ31, Kang YJ32, Jung SS33, Shin HJ34, Lee KJ35, Han SH7, Lee ES5, Han W36, Kim HJ2, Noh WC37.
    View PubMed
  • Oncol Rep. 2016 Apr;35(4):2398-404. doi: 10.3892/or.2016.4557. Epub 2016 Jan 13. MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells Kim S11, Jeon M1, Lee JE1, Nam SJ1.
    View PubMed
  • Medicine (Baltimore). 2016 Apr;95(16):e3299. doi: 10.1097/MD.0000000000003299. Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database Matched-Pair Analysis of Patients With Female Breast Cancer Choi MY11, Lee SK, Lee JE, Park HS, Lim ST, Jung Y, Ko BK, Nam SJ; Korean Breast Cancer Society.
    View PubMed
  • Tumour Biol. 2016 Apr;37(4):4991-9. doi: 10.1007/s13277-015-4345-7. Epub 2015 Nov 4. MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells Kim S11, Lee J2, Jeon M2,3, Lee JE2,3, Nam SJ4.
    View PubMed
  • Medicine (Baltimore). 2016 Mar;95(9):e3000. doi: 10.1097/MD.0000000000003000. Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Choi JS11, Ko ES, Ko EY, Han BK, Nam SJ.
    View PubMed
  • BMC Cancer. 2016 Feb 22;16:138. doi: 10.1186/s12885-016-2195-3. Prognostic value of ERBB4 expression in patients with triple negative breast cancer Kim JY11, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.
    View PubMed
  • Oncotarget. 2016 Jan 12;7(2):1544-58. doi: 10.18632/oncotarget.6441. Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-beta 1 signaling pathway Kim S11, Lee J1, Jeon M1,2, Lee JE1,2, Nam SJ1.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2453. doi: 10.1097/MD.0000000000002453. Assessment of Invasive Breast Cancer Heterogeneity Using Whole-Tumor Magnetic Resonance Imaging Texture Analysis Correlations With Detailed Pathological Findings Ko ES11, Kim JH, Lim Y, Han BK, Cho EY, Nam SJ.
    View PubMed
  • Oncotarget. 2015 Dec 22;6(41):43731-42. doi: 10.18632/oncotarget.6192. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer Lee JY11, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.
    View PubMed
  • Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Psychooncology. 2015 Dec;24(12):1723-30. doi: 10.1002/pon.3839. Epub 2015 May 26. Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT) Yun YH11,2, Jung JY1, Sim JA1, Choi H1, Lee JM3, Noh DY2,4, Han W2,4, Park KJ4, Jeong SY4, Park JW4, Wu HG5, Chie EK5, Kim HJ5, Lee JH6, Zo ZI7, Kim S8, Lee JE8, Nam SJ8, Lee ES3, Oh JH3, Kim YW3, Kim YT2,9, Shim YM7.
    View PubMed
  • PLoS One. 2015 Dec 2;10(12):e0144046. doi: 10.1371/journal.pone.0144046. eCollection 2015. Initial Experience with a Wireless Ultrasound-Guided Vacuum-Assisted Breast Biopsy Device Choi ER11, Han BK1, Ko ES1, Ko EY1, Choi JS1, Cho EY2, Nam SJ3.
    View PubMed
  • J Breast Cancer. 2015 Dec;18(4):386-93. doi: 10.4048/jbc.2015.18.4.386. Epub 2015 Dec 23. Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery Lee JH11, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.
    View PubMed
  • Ann Surg Oncol. 2015 Oct;22(11):3481-8. doi: 10.1245/s10434-015-4399-1. Epub 2015 Feb 5. The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women Kim J11, Han W2, Jung SY3, Park YH4, Moon HG5, Ahn SK6, Lee JW7, Kim MK5, Kim JJ5, Lee ES5, You TK1, Kang HS3, Lee ES3, Ro J3, Lee JE4, Nam SJ4, Yim YH4, Park IA5, Noh DY5.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):765-73. doi: 10.4143/crt.2014.168. Epub 2015 Jan 13. Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer Lee JY11, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.
    View PubMed
  • Technol Cancer Res Treat. 2015 Oct;14(5):525-9. doi: 10.7785/tcrt.2012.500415. Epub 2014 Nov 24. Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients Park JS11, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.
    View PubMed
  • Korean J Radiol. 2015 Sep-Oct;16(5):986-95. doi: 10.3348/kjr.2015.16.5.986. Epub 2015 Aug 21. Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype Ko ES11, Han H2, Han BK1, Kim SM3, Kim RB4, Lee GW5, Park YH6, Nam SJ7.
    View PubMed
  • Oncotarget. 2015 Sep 15;6(27):24499-510. Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay Park K11, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.
    View PubMed
  • J Breast Cancer. 2015 Sep;18(3):285-90. doi: 10.4048/jbc.2015.18.3.285. Epub 2015 Sep 24. Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast Park JS11, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.
    View PubMed
  • Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation Kim H11, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
    View PubMed
  • Mammographic density and risk of breast cancer in Korean women
  • Elevated TGF-beta 1 and -beta 2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells
  • Oncol Rep. 2015 Sep;34(3):1613-9. doi: 10.3892/or.2015.4116. Epub 2015 Jul 8. Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells Kim S11, Lee J1, Oh SJ1, Nam SJ1, Lee JE1.
    View PubMed
  • Breast Cancer Res Treat. 2015 Aug;152(3):675-82. doi: 10.1007/s10549-015-3502-4. Epub 2015 Jul 22. Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study Kang D11, Kim IR, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Park H, Kim E, Lee HK, Lee DY, Cho J.
    View PubMed
  • PLoS One. 2015 Aug 4;10(8):e0124658. doi: 10.1371/journal.pone.0124658. eCollection 2015. Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival Lee SK11, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.
    View PubMed
  • Breast. 2015 Jun;24(3):213-7. doi: 10.1016/j.breast.2015.01.012. Epub 2015 Feb 24. Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea Park YH11, Lee SJ1, Jung HA1, Kim SM1, Kim MJ1, Kil WH2, Lee JE2, Nam SJ2, Ahn JS1, Im YH3.
    View PubMed
  • Aesthetic Plast Surg. 2015 Jun;39(3):369-76. doi: 10.1007/s00266-015-0493-9. Epub 2015 Apr 30. Preoperative Magnetic Resonance Imaging-Based Breast Volumetry for Immediate Breast Reconstruction Kim H11, Mun GH, Wiraatmadja ES, Lim SY, Pyon JK, Oh KS, Lee JE, Nam SJ, Bang SI.
    View PubMed
  • J Breast Cancer. 2015 Jun;18(2):103-11. doi: 10.4048/jbc.2015.18.2.103. Epub 2015 Jun 26. The Basic Facts of Korean Breast Cancer in 2012: Results from a Nationwide Survey and Breast Cancer Registry Database Kim Z11, Min SY2, Yoon CS3, Jung KW4, Ko BS5, Kang E6, Nam SJ7, Lee S8, Hur MH3; Korean Breast Cancer Society.
    View PubMed
  • Oncology. 2015;88(6):337-44. doi: 10.1159/000368985. Epub 2015 Feb 25. Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer Lee SK11, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.
    View PubMed
  • Microsurgery. 2015 May;35(4):272-8. doi: 10.1002/micr.22328. Epub 2014 Sep 16. Is Holm Zone III safe from fat necrosis in medial row perforator-based deep inferior epigastric perforator flaps Lee KT11, Lee JE2, Nam SJ2, Han BK3, Mun GH1.
    View PubMed
  • Radiology. 2015 Apr;275(1):235-44. doi: 10.1148/radiol.14141129. Epub 2014 Dec 11. Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer Hyun SH11, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.
    View PubMed
  • Exp Cell Res. 2015 Apr 10;333(1):116-26. doi: 10.1016/j.yexcr.2015.02.019. Epub 2015 Mar 3. Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells Jeon M11, Lee J2, Nam SJ2, Shin I3, Lee JE4, Kim S5.
    View PubMed
  • Int J Cancer. 2015 Apr 15;136(8):1976-84. doi: 10.1002/ijc.29233. Epub 2014 Dec 24. A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery Park YH11, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.
    View PubMed
  • ANZ J Surg. 2015 Apr;85(4):240-4. Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone Rhu J1, Lee SK, Kil WH, Lee JE, Nam SJ.
    View PubMed
  • Surgery. 2015 Mar;157(3):518-25. doi: 10.1016/j.surg.2014.10.013. Epub 2014 Nov 6. Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study Lee SK11, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):8-15. doi: 10.4048/jbc.2015.18.1.8. Epub 2015 Mar 27. Survival Improvement in Korean Breast Cancer Patients Due to Increases in Early-Stage Cancers and Hormone Receptor Positive/HER2 Negative Subtypes: A Nationwide Registry-Based Study You JM11, Kim YG2, Moon HG2, Nam SJ3, Lee JW4, Lim W5, Lee MR6, Noh DY2, Han W2.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):22-8. doi: 10.4048/jbc.2015.18.1.22. Epub 2015 Mar 27. Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis Kim JY11, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.
    View PubMed
  • BMC Cancer. 2015 Mar 18;15:138. doi: 10.1186/s12885-015-1121-4. Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer Bae SY11, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27. Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
    View PubMed
  • Breast Cancer Res Treat. 2015 Feb;149(3):751-9. doi: 10.1007/s10549-015-3278-6. Epub 2015 Feb 1. Effect of menstrual cycle and menopausal status on apparent diffusion coefficient values and detectability of invasive ductal carcinoma on diffusion-weighted MRI Shin S11, Ko ES, Kim RB, Han BK, Nam SJ, Shin JH, Hahn SY.
    View PubMed
  • Tumour Biol. 2015 Feb;36(2):1073-9. doi: 10.1007/s13277-014-2730-2. Epub 2014 Oct 19. Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology Jung HA11, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.
    View PubMed
  • Aesthetic Plast Surg. 2015 Feb;39(1):162-70. doi: 10.1007/s00266-014-0436-x. Epub 2014 Dec 17. Effect of Antiadhesion Barrier Solution and Fibrin on Capsular Formation After Silicone Implant Insertion in a White Rat Model Lee SG11, Lee SD, Kim MK, Ryu WS, Jung SP, Kim S, Kim HY, Yoon ES, Kim CH, Nam SJ, Bae JW.
    View PubMed
  • Oncol Rep. 2014 Dec;32(6):2666-72. doi: 10.3892/or.2014.3514. Epub 2014 Sep 24. Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells Kim S11, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.
    View PubMed
  • Hum Pathol. 2014 Dec;45(12):2480-7. doi: 10.1016/j.humpath.2014.08.015. Epub 2014 Sep 7. Invasive Paget disease of the breast: 20 years of experience at a single institution Lee HW11, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.
    View PubMed
  • Asian Pac J Cancer Prev. 2014;15(20):8607-12. Association between Socioeconomic Status and Altered Appearance Distress, Body Image, and Quality of Life Among Breast Cancer Patients Chang O11, Choi EK, Kim IR, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Cho J.
    View PubMed
  • Phytother Res. 2014 Nov;28(11):1654-60. doi: 10.1002/ptr.5178. Epub 2014 May 30. Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells Han J11, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.
    View PubMed
  • Oncol Rep. 2014 Nov;32(5):2230-6. doi: 10.3892/or.2014.3450. Epub 2014 Aug 29. Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells Kim S11, Jeon M1, Lee J1, Han J1, Oh SJ1, Jung T1, Nam SJ1, Kil WH1, Lee JE1.
    View PubMed
  • Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23. Excision alone for small size ductal carcinoma in situ of the breast Kim H11, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.
    View PubMed
  • Ann Surg Treat Res. 2014 Oct;87(4):167-73. doi: 10.4174/astr.2014.87.4.167. Epub 2014 Sep 25. Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells Kil WH11, Kim SM1, Lee JE1, Park KS2, Nam SJ1.
    View PubMed
  • Breast. 2014 Oct;23(5):670-5. doi: 10.1016/j.breast.2014.07.005. Epub 2014 Jul 31. Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy Kim J11, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.
    View PubMed
  • Psychooncology. 2014 Oct;23(10):1103-10. doi: 10.1002/pon.3531. Epub 2014 Mar 24. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients Choi EK11, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH, Cho J.
    View PubMed
  • J Breast Cancer. 2014 Sep;17(3):244-9. doi: 10.4048/jbc.2014.17.3.244. Epub 2014 Sep 30. Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy Kil WH11, Lee JE1, Nam SJ1.
    View PubMed
  • Cancer Chemother Pharmacol. 2014 Sep;74(3):521-9. doi: 10.1007/s00280-014-2542-5. Epub 2014 Jul 22. Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer Choi MK11, Park YH, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.
    View PubMed
  • J Breast Cancer. 2014 Sep;17(3):279-86. doi: 10.4048/jbc.2014.17.3.279. Epub 2014 Sep 30. Breast Cancer Screening Knowledge and Perceived Health Beliefs among Immigrant Women in Korea Kim J11, Lee SK2, Lee J3, Choi MY3, Jung SP4, Kim MK2, Kim S2, Nam SJ2, Lee JE2, Kil WH2.
    View PubMed
  • Oncol Lett. 2014 Aug;8(2):507-512. Epub 2014 May 30. Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines Kim SH11, Lee HY2, Jung SP2, Kim S3, Lee JE3, Nam SJ3, Bae JW2.
    View PubMed
  • Oncology. 2014;86(5-6):279-88. doi: 10.1159/000362281. Epub 2014 Jun 4. Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers Park YH11, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.
    View PubMed
  • Tumour Biol. 2014 Jul;35(7):7079-84. doi: 10.1007/s13277-014-1952-7. Epub 2014 Apr 24. Aberrant DNA methylation of integrin alpha 4 in human breast cancer Do SI11, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.
    View PubMed
  • World J Surg. 2014 May;38(5):1065-9. doi: 10.1007/s00268-014-2468-4. The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer Lee SK11, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.
    View PubMed
  • J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1. Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection Noh JM11, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Radiology. 2014 Apr;271(1):30-7. doi: 10.1148/radiol.13131073. Epub 2013 Nov 21. Apparent Diffusion Coefficient in Estrogen Receptor-Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio Ko ES11, Han BK, Kim RB, Cho EY, Ahn S, Nam SJ, Ko EY, Shin JH, Hahn SY.
    View PubMed
  • Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12. Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population Noh JM11, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.
    View PubMed
  • Ann Surg Oncol. 2014 Apr;21(4):1231-6. doi: 10.1245/s10434-013-3350-6. Epub 2013 Dec 7. Effect of Axillary Lymph Node Dissection after Sentinel Lymph Node Biopsy on Overall Survival in Patients with T1 or T2 Node-positive Breast Cancer: Report from the Korean Breast Cancer Society Park HS11, Chae BJ, Song BJ, Jung SS, Han W, Nam SJ, Youn HJ, Ko BK, Kim DW; Korea Breast Cancer Society.
    View PubMed
  • Oncol Rep. 2014 Mar;31(3):1423-8. doi: 10.3892/or.2013.2936. Epub 2013 Dec 19. Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells Kim S11, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.
    View PubMed
  • BMC Cancer. 2014 Mar 10;14:170. doi: 10.1186/1471-2407-14-170. Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR) Kim J1, Lim W, Kim EK, Kim MK, Paik NS, Jeong SS, Yoon JH, Park CH, Ahn SH, Kim LS, Han S, Nam SJ, Kang HS, Kim SI, Yoo YB, Jeong J, Kim TH, Kang T, Kim SW, Jung Y, Lee JE, Kim KS, Yu JH, Chae BJ, Jung SY, Kang E, Choi SY, Moon HG, Noh DY, Han W1.
    View PubMed
  • J Breast Cancer. 2014 Mar;17(1):83-7. doi: 10.4048/jbc.2014.17.1.83. Epub 2014 Mar 28. Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ Lee JH11, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.
    View PubMed
  • Ann Oncol. 2014 Feb;25(2):346-51. doi: 10.1093/annonc/mdt476. Epub 2013 Dec 29. Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients Cho J11, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ.
    View PubMed
  • Cancer Res Treat. 2014 Jan;46(1):104-7. doi: 10.4143/crt.2014.46.1.104. Epub 2014 Jan 15. Primary Follicular Lymphoma in a Male Breast: A Case Report Jung SP11, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.
    View PubMed
  • Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations Park H11, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.
    View PubMed
  • J Breast Cancer. 2013 Dec;16(4):404-9. doi: 10.4048/jbc.2013.16.4.404. Epub 2013 Dec 31. Tubular Carcinoma of the Breast: Clinicopathologic Features and Survival Outcome Compared with Ductal Carcinoma In Situ Min Y11, Bae SY1, Lee HC1, Lee JH1, Kim M1, Kim J1, Lee SK1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.
    View PubMed
  • Cell Physiol Biochem. 2013;32(5):1541-50. doi: 10.1159/000356591. Epub 2013 Nov 29. Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells Kim S11, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ.
    View PubMed
  • Br J Surg. 2013 Dec;100(13):1756-63. doi: 10.1002/bjs.9337. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast Lee SK11, Yang JH, Woo SY, Lee JE, Nam SJ.
    View PubMed
  • J Korean Surg Soc. 2013 Nov;85(5):205-11. doi: 10.4174/jkss.2013.85.5.205. Epub 2013 Oct 25. Aromatase inhibitor-associated musculoskeletal symptoms: incidence and associated factors Park JY11, Lee SK, Bae SY, Kim J, Kim MK, Kil WH, Lee JE, Nam SJ.
    View PubMed
  • Fam Cancer. 2013 Mar;12(1):75-81. doi: 10.1007/s10689-012-9578-7. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study Han SA11, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.
    View PubMed
  • J Breast Cancer. 2013 Mar;16(1):16-22. doi: 10.4048/jbc.2013.16.1.16. Epub 2013 Mar 31. The Role of the CDH1 Promoter Hypermethylation in the Axillary Lymph Node Metastasis and Prognosis Jung SP11, Kim S, Nam SJ, Kim I, Bae JW.
    View PubMed
  • Anticancer Res. 2012 Dec;32(12):5459-64. Nationwide Survey of Use of Vacuum-assisted Breast Biopsy in South Korea Park HL11, Min SY, Kwon SH, Song JY, Shin H, Nam SJ, Yang JH; KOREAN BREAST CANCER SOCIETY MEMBERS.
    View PubMed
  • The Clinical Meaning of Intramammary Lymph Nodes
  • J Breast Cancer. 2012 Sep;15(3):359-63. doi: 10.4048/jbc.2012.15.3.359. Epub 2012 Sep 28. Occult Breast Cancers Manifesting as Axillary Lymph Node Metastasis in Men: A Two-Case Report Hur SM11, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Nam SJ, Lee JE, Yang JH.
    View PubMed
  • J Breast Cancer. 2012 Sep;15(3):296-305. doi: 10.4048/jbc.2012.15.3.296. Epub 2012 Sep 28. Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma Jung SP11, Lee JE, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ.
    View PubMed
  • Exp Mol Med. 2012 Aug 31;44(8):473-82. doi: 10.3858/emm.2012.44.8.054. A functional comparison between the HER2(high)/HER3 and the HER2l(ow/)HER3 dimers on heregulin-beta 1-induced MMP-1 and MMP-9 expression in breast cancer cells Kim S11, Han J, Shin I, Kil WH, Lee JE, Nam SJ.
    View PubMed
  • Oncology. 2012;83(1):31-7. doi: 10.1159/000336486. Epub 2012 Jun 21. Lymph Node Metastasis in Patients with Frozen Section Analyses That Are Negative for Tumors Lee SK11, Lee KW, Kim S, Choi MY, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ.
    View PubMed
  • J Surg Res. 2012 Jul;176(1):e21-9. doi: 10.1016/j.jss.2011.11.1041. Epub 2011 Dec 30. Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-alpha in Breast Cancer Cells Kim S11, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ.
    View PubMed
  • Asian Pac J Cancer Prev. 2012;13(4):1383-8. Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study Kim IR11, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, Nam SJ, Yang JH.
    View PubMed
  • Breast Cancer Res Treat. 2012 Apr;132(2):499-509. doi: 10.1007/s10549-011-1626-8. Epub 2011 Jun 11. A prognostic model for lymph node-negative breast cancer patients based on the integration of proliferation and immunity Oh E11, Choi YL, Park T, Lee S, Nam SJ, Shin YK.
    View PubMed
  • J Hum Genet. 2012 Mar;57(3):212-5. doi: 10.1038/jhg.2011.139. Epub 2012 Jan 5. Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing Jang JH11, Lee JE, Kwon MJ, Ki CS, Kim JW, Nam SJ, Yang JH.
    View PubMed
  • J Breast Cancer. 2012 Mar;15(1):98-104. doi: 10.4048/jbc.2012.15.1.98. Epub 2012 Mar 28. Long-Term Outcome of Internal Mammary Lymph Node Detected by Lymphoscintigraphy in Early Breast Cancer Koo MY11, Lee SK, Bae SY, Choi MY, Cho DH, Kim S, Lee JE, Nam SJ, Yang JH.
    View PubMed
  • Support Care Cancer. 2012 Mar;20(3):461-73. doi: 10.1007/s00520-011-1094-z. Epub 2011 Jan 28. Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study Kang E11, Yang EJ, Kim SM, Chung IY, Han SA, Ku DH, Nam SJ, Yang JH, Kim SW.
    View PubMed
  • Cancer Lett. 2012 Jan 28;314(2):147-54. doi: 10.1016/j.canlet.2011.09.024. Epub 2011 Sep 29. Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells Kim S11, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
    View PubMed
  • Breast Cancer Res. 2012 Jan 18;14(1):R14. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7 Kim SJ11, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH.
    View PubMed
  • Anticancer Res. 2011 Nov;31(11):3767-73. Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells Kim S11, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
    View PubMed
  • J Breast Cancer. 2011 Sep;14(3):251-2. doi: 10.4048/jbc.2011.14.3.251. Epub 2011 Sep 29. Invited Commentary on: Can CD44+/CD24-Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy Lee JE11, Nam SJ.
    View PubMed
  • J Breast Cancer. 2011 Jun;14(2):165-6. doi: 10.4048/jbc.2011.14.2.165. Epub 2011 Jun 18. Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic Lee JE11, Yang JH, Nam SJ.
    View PubMed
  • Survey of Psychosocial Problems Facing Breast Cancer Survivors after Undergoing a Mastectomy and Their Awareness of Breast Reconstruction
  • J Control Release. 2011 Nov 7;155(3):427-34. doi: 10.1016/j.jconrel.2011.06.026. Epub 2011 Jun 24. Development of microRNA-145 for therapeutic application in breast cancer Kim SJ11, Oh JS, Shin JY, Lee KD, Sung KW, Nam SJ, Chun KH.
    View PubMed
  • Phytomedicine. 2010 Dec 1;17(14):1127-32. doi: 10.1016/j.phymed.2010.03.013. 12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells Kim S11, Lee HS, Lee SK, Kim SH, Hur SM, Kim JS, Kim JH, Choe JH, Shin I, Yang JH, Lee JE, Nam SJ.
    View PubMed
  • The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study
  • Breast Cancer Res. 2010;12(6):R100. doi: 10.1186/bcr2783. Epub 2010 Nov 23. Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer Ko E11, Park SE, Cho EY, Kim Y, Hwang JA, Lee YS, Nam SJ, Bang S, Park J, Kim DH.
    View PubMed
  • J Surg Oncol. 2010 Oct 1;102(5):392-7. doi: 10.1002/jso.21424. The Role of PET CT to Evaluate the Response to Neoadjuvant Chemotherapy in Advanced Breast Cancer: Comparison With Ultrasonography and Magnetic Resonance Imaging Choi JH11, Lim HI, Lee SK, Kim WW, Kim SM, Cho E, Ko EY, Han BK, Park YH, Ahn JS, Im YH, Lee JE, Yang JH, Nam SJ.
    View PubMed
  • Secondary Partial Mastectomy with Contralateral Sentinel Lymph Node Biopsy for Ipsilateral Breast Cancer Recurrence after Conservative Surgery: Report of 2 Cases
  • Asia Pac J Clin Nutr. 2010;19(3):383-92. The association of carbohydrate intake, glycemic load, glycemic index, and selected rice foods with breast cancer risk: a case-control study in South Korea Yun SH11, Kim K, Nam SJ, Kong G, Kim MK.
    View PubMed
  • Nutr Cancer. 2010;62(5):555-66. doi: 10.1080/01635581003605557. Dietary Intake of Nitrate Relative to Antioxidant Vitamin in Relation to Breast Cancer Risk: A Case-Control Study Yang YJ11, Hwang SH, Kim HJ, Nam SJ, Kong G, Kim MK.
    View PubMed
  • Intracystic Papillary Carcinoma in the Male Breast
  • Biopsychosocial Predictors of the Quality of Life in Breast Cancer Patients
  • Br J Nutr. 2010 May;103(9):1345-53. doi: 10.1017/S0007114509993242. Epub 2009 Dec 8. A case-control study on seaweed consumption and the risk of breast cancer Yang YJ11, Nam SJ, Kong G, Kim MK.
    View PubMed
  • J Surg Oncol. 2010 Feb 1;101(2):137-40. doi: 10.1002/jso.21453. Characteristics of Metastasis in the Breast From Extramammary Malignancies Lee SK11, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.
    View PubMed
  • BMC Health Serv Res. 2010 Feb 23;10:48. doi: 10.1186/1472-6963-10-48. Association of shared decision-making with type of breast cancer surgery: a cross-sectional study Lee MK11, Noh DY, Nam SJ, Ahn SH, Park BW, Lee ES, Yun YH.
    View PubMed
  • Breast Cancer Res Treat. 2010 Jan;119(1):163-7. doi: 10.1007/s10549-009-0525-8. Does pre-operative breast magnetic resonance imaging in addition to mammography and breast ultrasonography change the operative management of breast carcinoma Lim HI11, Choi JH, Yang JH, Han BK, Lee JE, Lee SK, Kim WW, Kim S, Kim JS, Kim JH, Choe JH, Cho EY, Kang SS, Shin JH, Ko EY, Kim SW, Nam SJ.
    View PubMed
  • Implications of Isolated Tumor Cells in Sentinel Lymph Nodes of Breast Cancer Patients
  • Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System
  • Breast Cancer Res Treat. 2009 Nov;118(1):139-50. doi: 10.1007/s10549-009-0326-0. Epub 2009 Feb 4. Correlates of existential well-being and their association with health-related quality of life in breast cancer survivors compared with the general population Shin HW11, Noh DY, Lee ES, Nam SJ, Park BW, Ahn SH, Yun YH.
    View PubMed
  • Screening and Diagnosis for Breast Cancers
  • Commentary on "The Number of Removed Lymph Nodes for an Acceptable False Negative Rate in Sentinel Node Biopsy for Breast Cancer"
  • Breast Cancer Res Treat. 2009 Aug;116(3):609-16. doi: 10.1007/s10549-008-0209-9. Epub 2008 Oct 15. Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them Ahn E11, Cho J, Shin DW, Park BW, Ahn SH, Noh DY, Nam SJ, Lee ES, Yun YH.
    View PubMed
  • Phytomedicine. 2009 Jun;16(6-7):573-80. doi: 10.1016/j.phymed.2008.11.006. Epub 2009 Jan 31. Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells Kim S11, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.
    View PubMed
  • The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report
  • Clin Chim Acta. 2009 Feb;400(1-2):63-9. doi: 10.1016/j.cca.2008.10.014. Epub 2008 Oct 30. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers Woo HM11, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC.
    View PubMed
  • Breast Cancer Res Treat. 2009 Jan;113(1):83-93. doi: 10.1007/s10549-008-9909-4. Epub 2008 Jan 29. Expression of Bmi-1 protein in tumor tissues is associated with favorable prognosis in breast cancer patients Choi YJ11, Choi YL, Cho EY, Shin YK, Sung KW, Hwang YK, Lee SJ, Kong G, Lee JE, Kim JS, Kim JH, Yang JH, Nam SJ.
    View PubMed
  • Breast J. 2013 Jul-Aug;19(4):388-93. doi: 10.1111/tbj.12122. Epub 2013 May 31. The Impact of the Ratio of Positive Nodes to Removed Nodes on Recurrence and Overall Survival in Node Positive Breast Cancer Patients Martin FT11, O'Fearraigh C, Hanley C, Curran C, Sweeney KJ, Kerin MJ.
    View PubMed
  • Nutr Cancer. 2008;60(5):568-76. doi: 10.1080/01635580801966203. Dietary Intake of Soy Protein and Tofu in Association With Breast Cancer Risk Based on a Case-Control Study Kim MK11, Kim JH, Nam SJ, Ryu S, Kong G.
    View PubMed
  • Surg Today. 2008;38(5):390-4. doi: 10.1007/s00595-007-3653-y. Epub 2008 Apr 30. Intraoperative identification of suspicious palpable lymph nodes as an integral part of sentinel node biopsy in patients with breast cancer Choi YJ11, Kim JH, Nam SJ, Ko YH, Yang JH.
    View PubMed
  • Qual Life Res. 2008 Mar;17(2):215-25. Epub 2007 Dec 18. Association of clinical experiences with patient-reported outcomes among breast cancer surgery patients: breast cancer quality care study Noh DY11, Nam SJ, Ahn SH, Park BW, Lee ES, Lee MK, Kim SH, Kim YM, Park SM, Yun YH.
    View PubMed
  • Int J Cancer. 2008 Feb 15;122(4):919-23. A case-control study on the dietary intake of mushrooms and breast cancer risk among Korean women Hong SA11, Kim K, Nam SJ, Kong G, Kim MK.
    View PubMed
  • Breast Cancer Res Treat. 2007 Dec;106(2):245-53. Epub 2007 Feb 15. Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival Yun YH11, Park SM, Noh DY, Nam SJ, Ahn SH, Park BW, Lee ES.
    View PubMed
  • Ann Surg Oncol. 2007 Nov;14(11):3268-73. Epub 2007 Aug 29. Overexpression of interleukin-10 in sentinel lymph node with breast cancer Woo SU11, Bae JW, Yang JH, Kim JH, Nam SJ, Shin YK.
    View PubMed
  • J Korean Med Sci. 2007 Sep;22 Suppl:S17-23. Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer Choi J11, Hwang YK, Choi YJ, Yoo KE, Kim JH, Nam SJ, Yang JH, Lee SJ, Yoo KH, Sung KW, Koo HH, Im YH.
    View PubMed
  • Yonsei Med J. 2007 Jun 30;48(3):465-73. Analysis of prognostic factors and treatment modality changes in breast cancer: A single institution study in Korea Lee WS11, Lee JE, Kim JH, Nam SJ, Yang JH.
    View PubMed
  • Methylene blue for localization of sentinel lymph nodes in breast cancer: A comparison with isosulfan blue
  • Ann Oncol. 2007 Jan;18(1):173-82. Epub 2006 Oct 9. Health-related quality of life in disease-free survivors of breast cancer with the general population Ahn SH11, Park BW, Noh DY, Nam SJ, Lee ES, Lee MK, Kim SH, Lee KM, Park SM, Yun YH.
    View PubMed
  • Jpn J Clin Oncol. 2006 Aug;36(8):489-93. Epub 2006 Jun 20. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer Choi YJ11, Yun HR, Yoo KE, Kim JH, Nam SJ, Choi YL, Ko YH, Kim BT, Yang JH.
    View PubMed
  • Oncol Rep. 2006 Jul;16(1):119-22. Erlotinib prevents pulmonary metastasis in curatively resected breast carcinoma using a mouse model Choi YJ11, Nam SJ, Son MJ, Kim DK, Kim JH, Yang JH, Kim MH, Song HS, Nam DH, Bang SI.
    View PubMed
  • Hepatocellular carcinoma with metastasis to the breast
  • J Korean Med Sci. 2005 Oct;20(5):853-9. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas Choi YL11, Kim MK, Suh JW, Han J, Kim JH, Yang JH, Nam SJ.
    View PubMed
  • Arch Surg. 2005 Feb;140(2):125-8. Effect of core-needle biopsy vs fine-needle aspiration on pathologic measurement of tumor size in breast cancer Yang JH11, Lee WS, Kim SW, Woo SU, Kim JH, Nam SJ.
    View PubMed
  • Exp Mol Med. 2005 Feb 28;37(1):11-7. Genetic polymorphism of CYP17 and breast cancer risk in Korean women Shin MH11, Lee KM, Yang JH, Nam SJ, Kim JW, Yoo KY, Park SK, Noh DY, Ahn SH, Kim B, Kang D.
    View PubMed
  • J Korean Med Sci. 2004 Dec;19(6):826-33. E-cadherin and cytokeratin subtype profiling in effusion cytology Han J11, Kim MK, Nam SJ, Yang JH.
    View PubMed
  • Jpn J Clin Oncol. 2001 Jan;31(1):1-6. Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients Yang JH11, Nam SJ, Lee TS, Lee HK, Jung SH, Kim BT.
    View PubMed